• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE PRIMARY CELL IPG; DEEP BRAIN STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE PRIMARY CELL IPG; DEEP BRAIN STIMULATOR Back to Search Results
Model Number DB-1140
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Headache (1880); Muscular Rigidity (1968); Pain (1994); Anxiety (2328); Palpitations (2467); Patient Problem/Medical Problem (2688)
Event Type  Injury  
Manufacturer Narrative
Date of event: (b)(6) 2018 (exact date is unknown).Phone: (b)(6).A review of the manufacturing documentation for the ipg revealed that no anomalies or deviations potentially related to the event occurred during manufacturing.A review of the sterilization documentation for the device was found to be satisfactory.
 
Event Description
A report was received that the patient developed worsening parkinson¿s disease symptoms which were mild in severity.The patient was admitted, treated with medication, and the device was reprogrammed.The patient recovered and the event resolved, the patient was then discharged.The event was assessed as causally related to the study device stimulation and not related to the device or procedure.
 
Manufacturer Narrative
Additional information was received that detailed the patient symptoms and the hospitalization treatment.The patient experienced leg hypokinesia, unusually long off phases, stiffness in both arms, frontally accentuated bilateral headache radiating into the neck area, and tightness in the chest.Feelings of anxiety were associated with this episode, along with sweating and palpitations.During the admission the patient was observed to experience hypokinesia phase.Clinical examination during these phases showed a right-accentuated rigor, with bradykinesia and hypokinesia on the hand and the foot tapping and hand movements, and pain especially in the lower limbs when the patient was under psychological strain.The patient rapidly improved after administration of madopar lt, and stimulation was adjusted, medications were adjusted.
 
Event Description
A report was received that the patient developed worsening parkinson¿s disease symptoms which were mild in severity.The patient was admitted, treated with medication, and the device was reprogrammed.The patient recovered and the event resolved, the patient was then discharged.The event was assessed as causally related to the study device stimulation and not related to the device or procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE PRIMARY CELL IPG
Type of Device
DEEP BRAIN STIMULATOR
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer Contact
talar tahmasian
25155 rye canyon loop
valencia, CA 91355
6619494863
MDR Report Key7526258
MDR Text Key108656606
Report Number3006630150-2018-01746
Device Sequence Number1
Product Code NHL
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date12/04/2017
Device Model NumberDB-1140
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/24/2018
Initial Date FDA Received05/18/2018
Supplement Dates Manufacturer Received06/07/2018
Supplement Dates FDA Received06/14/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/09/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age58 YR
-
-